{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T03:57:29Z","timestamp":1773115049146,"version":"3.50.1"},"reference-count":43,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Investigation"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.resinv.2025.11.002","type":"journal-article","created":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T21:09:31Z","timestamp":1763068171000},"page":"1369-1376","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Fractional exhaled nitric oxide as a biomarker for the evaluating asthmatic patients with allergic bronchopulmonary mycosis"],"prefix":"10.1016","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-6153-9160","authenticated-orcid":false,"given":"Kazuki","family":"Matsuda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiji","family":"Oishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junki","family":"Suizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayumi","family":"Fukatsu-Chikumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keita","family":"Murakawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5082-1486","authenticated-orcid":false,"given":"Kazuki","family":"Hamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuichiro","family":"Ohata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryo","family":"Suetake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiaki","family":"Utsunomiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoriyuki","family":"Murata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshikazu","family":"Yamaji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0981-1614","authenticated-orcid":false,"given":"Taiga","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5218-6132","authenticated-orcid":false,"given":"Maki","family":"Asami-Noyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobutaka","family":"Edakuni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5475-0806","authenticated-orcid":false,"given":"Tsunahiko","family":"Hirano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1339-1031","authenticated-orcid":false,"given":"Tomoyuki","family":"Kakugawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuto","family":"Matsunaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.resinv.2025.11.002_bib1","doi-asserted-by":"crossref","first-page":"e24","DOI":"10.5415\/apallergy.2018.8.e24","article-title":"Allergic bronchopulmonary mycosis - pathophysiology, histology, diagnosis, and treatment","volume":"8","author":"Asano","year":"2018","journal-title":"Asia Pac Allergy"},{"issue":"4","key":"10.1016\/j.resinv.2025.11.002_bib42","doi-asserted-by":"crossref","first-page":"361","DOI":"10.3109\/13693786.2012.738312","article-title":"Global burden of allergic bronchopulmonary aspergillosis with asthma and its complication chronic pulmonary aspergillosis in adults","volume":"51","author":"Denning","year":"2013","journal-title":"Med Mycol"},{"issue":"12","key":"10.1016\/j.resinv.2025.11.002_bib43","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1111\/cea.12595","article-title":"Prevalence of aspergillus sensitization and allergic bronchopulmonary aspergillosis in cystic fibrosis: systematic review and meta-analysis","volume":"45","author":"Maturu","year":"2015","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.resinv.2025.11.002_bib2","doi-asserted-by":"crossref","first-page":"361","DOI":"10.3109\/13693786.2012.738312","article-title":"Global burden of allergic bronchopulmonary aspergillosis with asthma and its complication chronic pulmonary aspergillosis in adults","volume":"51","author":"Denning","year":"2013","journal-title":"Med Mycol"},{"key":"10.1016\/j.resinv.2025.11.002_bib3","first-page":"1","article-title":"Basic aspects of exhaled nitric oxide","volume":"49","author":"Alving","year":"2010","journal-title":"European Respiratory Society Monograph"},{"key":"10.1016\/j.resinv.2025.11.002_bib4","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1172\/JCI84910","article-title":"Epithelial tethering of MUC5AC-rich mucus impairs mucociliary transport in asthma","volume":"126","author":"Bonser","year":"2016","journal-title":"J Clin Investig"},{"key":"10.1016\/j.resinv.2025.11.002_bib20","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.3389\/fimmu.2018.02346","article-title":"Allergic bronchopulmonary Aspergillosis-A luminal hypereosinophilic disease with extracellular trap cell death","volume":"9","author":"Ueki","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.resinv.2025.11.002_bib5","first-page":"164","article-title":"Guideline for allergic bronchopulmonary mycosis","volume":"69","author":"Asano","year":"2020","journal-title":"Arerugi"},{"key":"10.1016\/j.resinv.2025.11.002_bib6","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1164\/rccm.200406-710ST","article-title":"ATS\/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005","volume":"171","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2025.11.002_bib7","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1183\/09031936.05.00034805","article-title":"Standardisation of spirometry","volume":"26","author":"Miller","year":"2005","journal-title":"Eur Respir J"},{"issue":"8","key":"10.1016\/j.resinv.2025.11.002_bib44","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1111\/all.12644","article-title":"Novel scoring system and algorithm for classifying chronic rhinosinusitis: the JESREC study","volume":"70","author":"Tokunaga","year":"2015","journal-title":"Allergy"},{"key":"10.1016\/j.resinv.2025.11.002_bib8","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1172\/JCI95693","article-title":"Mucus plugs in patients with asthma linked to eosinophilia and airflow obstruction","volume":"128","author":"Dunican","year":"2018","journal-title":"J Clin Investig"},{"key":"10.1016\/j.resinv.2025.11.002_bib9","first-page":"649","article-title":"High attenuation mucous plugs in allergic bronchopulmonary aspergillosis: CT appearance","volume":"16","author":"Goyal","year":"1992","journal-title":"J Comput Assist Tomogr"},{"key":"10.1016\/j.resinv.2025.11.002_bib10","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1067\/j.cpradiol.2015.07.006","article-title":"High-attenuation mucus impaction in patients with allergic bronchopulmonary aspergillosis: objective criteria on high-resolution computed tomography and correlation with serologic parameters","volume":"45","author":"Phuyal","year":"2016","journal-title":"Curr Probl Diagn Radiol"},{"key":"10.1016\/j.resinv.2025.11.002_bib11","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software 'EZR' for medical statistics","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.resinv.2025.11.002_bib12","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.resinv.2020.05.006","article-title":"An official JRS statement: the principles of fractional exhaled nitric oxide (FeNO) measurement and interpretation of the results in clinical practice","volume":"59","author":"Matsunaga","year":"2021","journal-title":"Respir Investig"},{"key":"10.1016\/j.resinv.2025.11.002_bib13","article-title":"Exhaled nitric oxide and olfactory dysfunction in patients with asthma: association with chronic rhinosinusitis","volume":"59","author":"Oda","year":"2023","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.resinv.2025.11.002_bib14","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.resinv.2020.08.004","article-title":"Evaluation of olfactory dysfunction to estimate the presence of eosinophilic chronic rhinosinusitis in patients with asthma","volume":"59","author":"Takahashi","year":"2021","journal-title":"Respir Investig"},{"key":"10.1016\/j.resinv.2025.11.002_bib15","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.4049\/jimmunol.1302984","article-title":"IL-33 and thymic stromal lymphopoietin mediate immune pathology in response to chronic airborne allergen exposure","volume":"193","author":"Iijima","year":"2014","journal-title":"J Immunol"},{"key":"10.1016\/j.resinv.2025.11.002_bib16","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jaci.2014.11.037","article-title":"Persistence of asthma requires multiple feedback circuits involving type 2 innate lymphoid cells and IL-33","volume":"136","author":"Christianson","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.resinv.2025.11.002_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2017.07.048","article-title":"Eosinophils release extracellular DNA traps in response to Aspergillus fumigatus","volume":"141","author":"Muniz","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.resinv.2025.11.002_bib18","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s11882-016-0634-5","article-title":"Eosinophil ETosis and DNA traps: a new look at eosinophilic inflammation","volume":"16","author":"Ueki","year":"2016","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.resinv.2025.11.002_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0061105","article-title":"Diagnostic performance of various tests and criteria employed in allergic bronchopulmonary aspergillosis: a latent class analysis","volume":"8","author":"Agarwal","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.resinv.2025.11.002_bib21","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1111\/cea.12141","article-title":"Allergic bronchopulmonary aspergillosis: review of literature and proposal of new diagnostic and classification criteria","volume":"43","author":"Agarwal","year":"2013","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.resinv.2025.11.002_bib22","doi-asserted-by":"crossref","first-page":"405","DOI":"10.7326\/0003-4819-86-4-405","article-title":"Clinical and immunologic criteria for the diagnosis of allergic bronchopulmonary aspergillosis","volume":"86","author":"Rosenberg","year":"1977","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.resinv.2025.11.002_bib23","article-title":"The correlation between fractional exhaled nitric oxide (FeNO), blood eosinophil count, immunoglobulin E levels, and spirometric values in patients with asthma","volume":"15","author":"Al Ghobain","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.resinv.2025.11.002_bib24","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.alit.2015.12.006","article-title":"Persistently high exhaled nitric oxide and loss of lung function in controlled asthma","volume":"65","author":"Matsunaga","year":"2016","journal-title":"Allergol Int"},{"key":"10.1016\/j.resinv.2025.11.002_bib25","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1111\/j.1365-2222.2011.03945.x","article-title":"Associated demographics of persistent exhaled nitric oxide elevation in treated asthmatics","volume":"42","author":"Matsunaga","year":"2012","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.resinv.2025.11.002_bib26","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s12931-024-02665-w","article-title":"Mucus plugs in the airways of asthmatic subjects and smoking status","volume":"25","author":"Audousset","year":"2024","journal-title":"Respir Res"},{"key":"10.1016\/j.resinv.2025.11.002_bib27","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.alit.2024.01.013","article-title":"Associations of fractional exhaled nitric oxide with airway dimension and mucus plugs on ultra-high-resolution computed tomography in former smokers and nonsmokers with asthma","volume":"73","author":"Hayashi","year":"2024","journal-title":"Allergol Int"},{"key":"10.1016\/j.resinv.2025.11.002_bib28","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-10504-w","article-title":"Relationship between fraction of exhaled nitric oxide and airway morphology assessed by three-dimensional CT analysis in asthma","volume":"7","author":"Nishimoto","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.resinv.2025.11.002_bib29","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1056\/NEJMoa1804092","article-title":"Dupilumab efficacy and safety in moderate-to-severe uncontrolled asthma","volume":"378","author":"Castro","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.resinv.2025.11.002_bib30","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1016\/S0140-6736(16)31324-1","article-title":"Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting \u03b2(2)-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial","volume":"388","author":"Bleecker","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.resinv.2025.11.002_bib31","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1056\/NEJMoa1403290","article-title":"Mepolizumab treatment in patients with severe eosinophilic asthma","volume":"371","author":"Ortega","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.resinv.2025.11.002_bib32","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1016\/j.rmed.2007.01.011","article-title":"Predicting and evaluating response to omalizumab in patients with severe allergic asthma","volume":"101","author":"Bousquet","year":"2007","journal-title":"Respir Med"},{"key":"10.1016\/j.resinv.2025.11.002_bib33","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1002\/iid3.233","article-title":"Three-step algorithm for biological therapy targeted IgE and IL-5 in severe asthma","volume":"6","author":"Oishi","year":"2018","journal-title":"Immun Inflamm Dis"},{"key":"10.1016\/j.resinv.2025.11.002_bib34","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.alit.2020.01.002","article-title":"Dupilumab: basic aspects and applications to allergic diseases","volume":"69","author":"Matsunaga","year":"2020","journal-title":"Allergol Int"},{"key":"10.1016\/j.resinv.2025.11.002_bib35","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1016\/j.jaip.2018.11.024","article-title":"Allergic bronchopulmonary aspergillosis successfully treated with benralizumab","volume":"7","author":"Soeda","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.resinv.2025.11.002_bib36","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s12890-018-0617-5","article-title":"A case of allergic bronchopulmonary aspergillosis successfully treated with mepolizumab","volume":"18","author":"Terashima","year":"2018","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.resinv.2025.11.002_bib37","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.jaip.2014.12.008","article-title":"Clinical efficacy and immunologic effects of omalizumab in allergic bronchopulmonary aspergillosis","volume":"3","author":"Voskamp","year":"2015","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.resinv.2025.11.002_bib38","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1136\/thx.2004.035519","article-title":"Successful treatment of allergic bronchopulmonary aspergillosis with recombinant anti-IgE antibody","volume":"62","author":"van der Ent","year":"2007","journal-title":"Thorax"},{"key":"10.1016\/j.resinv.2025.11.002_bib40","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s13223-020-00454-w","article-title":"Differential response to biologics in a patient with severe asthma and ABPA: a role for dupilumab?","volume":"16","author":"M\u00fcmmler","year":"2020","journal-title":"Allergy Asthma Clin Immunol"},{"key":"10.1016\/j.resinv.2025.11.002_bib41","doi-asserted-by":"crossref","first-page":"331","DOI":"10.2332\/allergolint.10-OA-0277","article-title":"Exhaled nitric oxide cutoff values for asthma diagnosis according to rhinitis and smoking status in Japanese subjects","volume":"60","author":"Matsunaga","year":"2011","journal-title":"Allergol Int"}],"container-title":["Respiratory Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212534525001789?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212534525001789?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T08:00:42Z","timestamp":1763625642000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212534525001789"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":43,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S2212534525001789"],"URL":"https:\/\/doi.org\/10.1016\/j.resinv.2025.11.002","relation":{},"ISSN":["2212-5345"],"issn-type":[{"value":"2212-5345","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fractional exhaled nitric oxide as a biomarker for the evaluating asthmatic patients with allergic bronchopulmonary mycosis","name":"articletitle","label":"Article Title"},{"value":"Respiratory Investigation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.resinv.2025.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Japanese Respiratory Society. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}